← Open Payments lookup

AMBER GOLD: Open Payments

NPI 1083205561 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,357 in 75 payments from 15 companies in 2025. Trend: 2023 $2,144 · 2024 $567 · 2025 $1,357

Food & beverage: $1,357
CompanyPaymentsAmount
Alkermes, Inc.15$281
ABBVIE INC.16$203
Almatica Pharma LLC8$144
Supernus Pharmaceuticals, Inc.8$131
Takeda Pharmaceuticals U.S.A., Inc.5$106
Otsuka America Pharmaceutical, Inc.5$103
Teva Pharmaceuticals USA, Inc.4$87
Axsome Therapeutics, Inc.4$79
E.R. Squibb & Sons, L.L.C.3$71
Neurocrine BioSciences, Inc.2$36

Products named: ARISTADA, VRAYLAR, LOREEV XR, Qelbree, REXULTI, TRINTELLIX, UZEDY, Auvelity.

Industry payments across NC — which companies pay providers there.